Welcome to the tag category page for Endocrinology!
Wegovy is a prescription medication for adults with obesity or overweight. It contains semaglutide and works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food. It is used as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management. Patients taking Wegovy lost an average of 35 lbs over 68 weeks, and 83% of them lost 5% or more of their weight. Wegovy comes in 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg pens, while Ozempic is available in 0.25 mg, 0.5 mg, and 1.0 mg pens. It may take several weeks or months before a person notices weight loss or a decrease in appetite from Wegovy.
Rybelsus is a prescription medication used to treat type 2 diabetes in adults. It comes in tablet form and is taken orally. The medication is available in two dosages: 7 mg and 14 mg. Rybelsus is intended to be used in conjunction with a healthy diet and exercise to help control blood sugar levels. It works by mimicking the effects of GLP-1, a naturally occurring incretin hormone that is usually released following a meal. Rybelsus stimulates the secretion of insulin following food, reduces the amount of glucose produced by the liver, and helps to make you feel full after food. The medication is not currently approved for weight loss, although it can be a possible side effect. Rybelsus is different from Metformin, which is an older drug and usually prescribed as the first medication for type 2 diabetes. The cost of Rybelsus without insurance varies by retailer and averages around $350 per month.
Continuous Glucose Monitoring (CGM) is a cutting-edge technology that allows individuals with diabetes to constantly monitor their blood sugar levels throughout the day and night. CGMs use small sensor-based systems that provide glucose readings and can help simplify diabetes management. These devices require a prescription and can cost between $1,000 to $3,000 a year, with options to connect health-conscious consumers with CGMs online. CGMs are essential tools for people with diabetes or prediabetes to track and manage their condition effectively. By providing real-time updates on blood glucose levels, CGMs offer valuable insights and information to help individuals make informed decisions regarding their health and well-being.
Continuous Glucose Monitoring (CGM) is a device that automatically tracks blood glucose levels throughout the day and night, giving insights into where glucose levels were, where they are, and where they are headed. CGM systems use a tiny sensor inserted under the skin on the abdomen or arm that tracks glucose levels every few minutes. It is approved for use by adults and children with a prescription and is recommended for patients on intensive insulin therapy. The average starting cost for a CGM system is around $1,000, and Medicare covers it through the durable medical equipment benefit. The major limitation of CGM is the measurement of interstitial glucose levels rather than real-time blood glucose levels, which causes a delay in treatment for hyperglycemia and hypoglycemia in patients.
The side effects of Ozempic include nausea, vomiting, diarrhea, stomach pain, constipation, gas, and burping. These may be temporary and can last for a few weeks. Ozempic helps to lower blood sugar levels and reduce the sugar released by the liver, but it may also cause new or worsening kidney disease, including kidney failure, in some people. Other rare side effects may include blistering, burning, hives, and infection. To relieve indigestion symptoms, eat smaller portions of food throughout the day. Overall, it is important to be aware of the potential side effects of Ozempic and to speak with your doctor if you experience any concerning symptoms.
Ozempic Injection is a once-weekly noninsulin medication used to improve blood sugar in adults with type 2 diabetes when used with diet and exercise. It is injected under the skin of the abdomen, thigh, or upper arm and may help with weight loss. The main active ingredient is semaglutide, which stimulates insulin secretion to lower fasting and postprandial blood glucose levels. It may cause or worsen kidney disease, and doctors may closely monitor kidney health during treatment. It starts working shortly after injection, but it may take several weeks to get the full benefit.
